- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Glenmark Pharma rises after zanubrutinib launch in India | 3 | capitalmarket.com | ||
| 02.06. | Ichnos Glenmark Innovation: Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma | 262 | PR Newswire | TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy
ORR is remarkably high... ► Artikel lesen | |
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 06.05. | Ichnos Glenmark Innovation (IGI) erhält FDA-Fast-Track-Zulassung für ISB 2001 zur Behandlung des rezidivierten/refraktären multiplen Myeloms | 306 | news aktuell | New York (ots/PRNewswire) - Ergebnisse des Dosis-Eskalationsteils der klinischen Phase-1-Studie mit ISB 2001 bei Patienten mit stark vorbehandeltem multiplem Myelom werden auf der ASCO-Jahrestagung... ► Artikel lesen | |
| 05.05. | Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma | 264 | PR Newswire | Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001 in patients with heavily pretreated multiple myeloma to be presented at the 2025 ASCO Annual Meeting
NEW... ► Artikel lesen | |
| 17.04. | Glenmark Pharma's US arm set to launch generic Adderall tablets | 3 | capitalmarket.com | ||
| 16.04. | Glenmark To Launch Generic Adderall Tablets In May 2025 | 415 | AFX News | WASHINGTON (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited (GLENMARK.NS) Wednesday announced its upcoming May 2025 launch of a generic... ► Artikel lesen | |
| 13.04. | Glenmark, Sun Pharma, Zydus Recall Medicines In US Over Manufacturing Issues | 3 | The Free Press Journal | ||
| 11.04. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 3 | capitalmarket.com | ||
| 01.04. | Glenmark Launches Vancomycin Hydrochloride For Injection In 3 Doses | 306 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP... ► Artikel lesen | |
| 01.04. | Glenmark launches Vancomycin Hydrochloride for injection USP in the USA | 4 | capitalmarket.com | ||
| 25.03. | Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines | 309 | PR Newswire | MANILA, Philippines, March 25, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation... ► Artikel lesen | |
| 21.03. | Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution | 3 | capitalmarket.com | ||
| 21.03. | Glenmark Gets FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) | 428 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic... ► Artikel lesen | |
| 21.03. | Stock Alert: Hindustan Unilever, Hindalco Inds, Glenmark Pharma, Ashoka Buildcon | 5 | capitalmarket.com | ||
| 12.03. | Glenmark Pharma launches generic Empagliflozin in India | 4 | capitalmarket.com | ||
| 10.03. | Glenmark Pharma launches osmotic laxative Polyethylene Glycol in US | 2 | capitalmarket.com | ||
| 04.03. | Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug | 10 | FiercePharma | ||
| 04.03. | Glenmark Pharma launches Acetylcysteine injection in US; long-term positive? | 6 | ZEE Business | ||
| 03.03. | Glenmark Acquires and Launches Acetylcysteine Injection | 2 | Contract Pharma | ||
| 03.03. | Glenmark Pharmaceuticals USA Buys, Launches Acetylcysteine Injection 6 Gm/30 ML Single-Dose Vials | 301 | AFX News | NEW DELHI (dpa-AFX) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine... ► Artikel lesen |
1 2 3 4 Weiter >>
66 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,098 | -0,57 % | SINOPHARM (01099): PROPOSED DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | ||
| CSPC PHARMA | 0,990 | -0,90 % | Broadcom | Lululemon | Adidas - CSPC Pharmaceutical & Nebius gehen steil! | Markus Weingran - Mein Tipp: SMARTBROKER+: https://dwbdiv.smartbrokerplus.de/ts/94450/tsc - typ=r&amc=con.smartbrokerplus.536232.548190.CRTuFopWREk&smc1=YouTube (Werbung) Willkommen bei der Börsenlounge... ► Artikel lesen | |
| WUXI BIOLOGICS | 3,060 | +2,75 % | WuXi Biologics-Aktie im Höhenflug: Papier legt um 6,00 Prozent zu (2,949 €) | Die Aktie von WuXi Biologics zählt am Montag zu den großen Gewinnern an der Börse. Der Titel steigt deutlich. Grund zur Freude haben Aktionäre von WuXi Biologics: Das Papier weist aktuell einen Preisanstieg... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,886 | -3,13 % | FOSUN PHARMA (02196): ANNOUNCEMENT REGARDING ELECTION OF EMPLOYEE DIRECTOR | ||
| GEDEON RICHTER | 25,000 | -2,42 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 13,600 | -0,73 % | Dr Reddys Laboratories Ltd up for third consecutive session | ||
| ASPEN PHARMACARE | 6,000 | +2,56 % | ASPEN PHARMACARE HOLDINGS LIMITED - Notification in Terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements | ||
| SHANGHAI PHARMACEUTICALS | 1,330 | +1,53 % | SH PHARMA (02607): FINAL DIVIDENDS FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) | ||
| LUYE PHARMA | 0,406 | +6,28 % | LUYE PHARMA (02186): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,124 | +2,48 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT NDA OF BIREOCICLIB TABLETS' NEW INDICATION, IN COMBINATION WITH AROMATASE INHIBITOR FOR FIRST-LINE TREATMENT ... | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,575 | 0,00 % | CHINARES PHARMA (03320): DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,865 | +2,37 % | SHINEWAY PHARM (02877): APPOINTMENT OF MEMBER OF NOMINATION COMMITTEE | ||
| HANSOH PHARMACEUTICAL | 3,360 | +1,20 % | HSI Down 331 pts; HSTI Down 119 pts; BABA Down over 3%; SINO BIOPHARM, ZIJIN MINING, WUXI APPTEC, HANSOH PHARMA, CHOW TAI FOOK Hit New Highs; Market Turnover Rises | ||
| KALBE FARMA | 0,078 | 0,00 % | KLBF subsidiary partners with GE HealthCare to produce local CT scans: KLBF inaugurates new factory ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.